ロード中...
BISPHOSPHONATES FOR THE TREATMENT OF CALCITRIOL-INDUCED HYPERCALCEMIA
OBJECTIVE: Calcitriol excess is a less common cause of hypercalcemia than hyperparathyroidism. Hypercalcemia due to calcitriol excess is usually managed acutely with intravenous (IV) fluid administration and dietary calcium restriction. Steroids and ketoconazole are second-line agents. There is evid...
保存先:
| 出版年: | AACE Clin Case Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Association of Clinical Endocrinologists
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6876953/ https://ncbi.nlm.nih.gov/pubmed/31967061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2019-0101 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|